Stay updated on Amivantamab in Adenoid Cystic Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Amivantamab in Adenoid Cystic Carcinoma Clinical Trial page.

Latest updates to the Amivantamab in Adenoid Cystic Carcinoma Clinical Trial page
- Check3 days agoChange DetectedThe page's revision indicator was updated from v3.6.3 to v3.6.4, signaling a new release of the page without changes to the study data presented.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check25 days agoChange DetectedThe page's revision label changed from v3.6.0 to v3.6.3, signaling a newer version of the page template or content.SummaryDifference0.1%

- Check39 days agoChange DetectedAdded new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and a recruitment note 'No longer looking for participants'; standardized the label from 'Intervention / Treatment' to 'Intervention/Treatment', and updated the revision tag from v3.5.5 to v3.6.0.SummaryDifference0.4%

- Check46 days agoChange DetectedThe page's revision tag was updated from v3.5.4 to v3.5.5, indicating a new version of the page documentation.SummaryDifference0.1%

- Check67 days agoChange DetectedThe page revision tag was updated from v3.5.3 to v3.5.4, indicating a minor update to the page metadata.SummaryDifference0.1%

- Check74 days agoChange DetectedThe page now includes posted results with dates and the associated outcome measures, safety data, and QoL, plus links to the Study Protocol and Statistical Analysis Plan, reflecting updated documentation for the study record.SummaryDifference2%

Stay in the know with updates to Amivantamab in Adenoid Cystic Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Amivantamab in Adenoid Cystic Carcinoma Clinical Trial page.